These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3547612)

  • 21. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on anti-ulcer effects of a new compound, zinc L-carnosine (Z-103)].
    Seiki M; Ueki S; Tanaka Y; Soeda M; Hori Y; Aita H; Yoneta T; Morita H; Tagashira E; Okabe S
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):257-69. PubMed ID: 2113032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical therapy of peptic ulcer disease.
    McQuaid KR; Isenberg JI
    Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of ulcers with pirenzepin. Results from clinic and practice].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting quality of ulcer healing after lansoprazole treatment.
    Ito G; Nakagawara M; Watanabe F; Ooi S; Nawano M; Hanai H; Kaneko E
    J Clin Gastroenterol; 1995; 20 Suppl 2():S62-6. PubMed ID: 7594344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The other option in peptic ulcer therapy.
    Halter F
    S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse rates following initial ulcer healing with sucralfate and cimetidine.
    Marks IN; Wright JP; Lucke W; Girdwood AH
    Scand J Gastroenterol Suppl; 1983; 83():53-6. PubMed ID: 6579632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sucralfate: worldwide experience in recurrence therapy.
    Marks IN
    J Clin Gastroenterol; 1987; 9 Suppl 1():18-22. PubMed ID: 3302008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
    Lai KC; Hui WM; Wong BC; Hu WH; Lam SK
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1071-6. PubMed ID: 10930902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of the gastric stump ulcer: an open study with five drugs.
    Janke A; Stasiewicz J; Namiot Z; Szalaj W
    Hepatogastroenterology; 2000; 47(34):1195-8. PubMed ID: 11020913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current trends in medical therapy of gastroduodenal ulcer].
    Grassi M; Fraioli A; Messina B
    Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel therapeutic approaches to gastric and duodenal ulcers: an update.
    Dajani EZ; Klamut MJ
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1537-44. PubMed ID: 11060758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental evaluation of Bocopa monniera on rat gastric ulceration and secretion.
    Rao CV; Sairam K; Goel RK
    Indian J Physiol Pharmacol; 2000 Oct; 44(4):435-41. PubMed ID: 11214498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
    Maev IV; Samsonov AA; Golubev NN
    Klin Med (Mosk); 2008; 86(9):57-63. PubMed ID: 19048841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats.
    Segami T; Suzuki Y; Ito M
    Biol Pharm Bull; 1996 Jan; 19(1):53-6. PubMed ID: 8820911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.